ImmunityBio (IBRX) Debt Ratio (2015 - 2026)

ImmunityBio (IBRX) has 12 years of Debt Ratio data on file, last reported at 0.63 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 35.9% year-over-year to 0.63 in Q1 2026; TTM through Mar 2026 was 0.63, a 35.9% decrease from a year earlier, with the FY2025 full-year figure at 0.65, down 12.92% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.63, down from 0.65 in the prior quarter.
• Over the last five years, Debt Ratio for IBRX reached as high as 1.11 in Q3 2023 and fell as low as 0.24 in Q2 2024.
• Historically, Debt Ratio has averaged 0.69 across 5 years, with a median of 0.72 in 2023.
• Across the five-year window, Debt Ratio plunged 72.54% in 2024 and soared 211.84% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 1.06 in 2022, then slumped by 70.87% to 0.31 in 2023, then jumped by 141.07% to 0.74 in 2024, then declined by 12.92% to 0.65 in 2025, then decreased by 3.33% to 0.63 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.63 in Q1 2026, 0.65 in Q4 2025, and 0.61 in Q3 2025.